Effect of serial awake prone positioning on oxygenation in patients admitted to intensive care with COVID-19. Issue 1159 (30th April 2021)

• Record Type: Journal Article
• Authors: Barker, Joseph; Pan, Daniel; Koeckerling, David; Baldwin, Alexander James; West, Raha
• Is Part Of: Postgraduate medical journal. Volume 98:Issue 1159(2022)
• Page Start: 360
• Page End: 364
• Publication Date: 2021-04-30
• Subjects: COVID-19 -- adult intensive & critical care -- respiratory infections; Medicine -- Periodicals; 610
• DOI: 10.1136/postgradmedj-2020-139631
• Languages: English
• ISSNs: 0032-5473

Abstract

Abstract : Introduction: Awake prone positioning (APP) might benefit patients with COVID-19 by improving oxygenation, but it is unknown whether this improvement can be sustained with serial proning episodes. Methods: We conducted a retrospective review of adults with COVID-19 admitted to one intensive care unit, in those who underwent APP and controls. Patients in both groups had type 1 respiratory failure requiring oxygen (but not initially intubated), confirmed SARS-CoV-2 PCR by nasopharyngeal swab and findings of multifocal ground-glass opacities on imaging. For the APP group, serial SpO2 /FiO2 measurements were recorded after each proning episode. Results: Of 77 patients admitted, 50 (65%) were excluded because they had already been intubated. Another 7 (9%) had undergone APP prior to admission. Of the remaining 20, 10 underwent APP and 10 were controls. Patients in both groups had similar demographics, subsequent intubation and survival. Of those who underwent APP, SpO2 /FiO2 was most likely to increase after the first episode (before median: 152, IQR 135–185; after: median 192, IQR 156–234, p=0.04). Half of participants (5) in the APP group were unable to tolerate more than two APP episodes. Conclusions: Most patients with COVID-19 admitted to the intensive care are not suitable for APP. Of those who are, many cannot tolerate more than two episodes. Improvements in SpO2 /FiO2 secondary to APP are transient and most likely in the first episode. Our findings may explain why other studies have failed to show improvements in mortality from APP despite improvements in oxygenation.